12 Best Get Rich Fast Stocks To Buy Now

Page 2 of 12

11. CureVac N.V. (NASDAQ:CVAC)

Number of Hedge Fund Holders: 6    

CureVac N.V. (NASDAQ:CVAC)  is a clinical-stage biopharmaceutical company that focuses on developing various transformative medicines based on messenger ribonucleic acid. It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2, CV7202 which is in Phase 1 clinical trial for the treatment of rabies, and CVSQIV to treat multivalent seasonal influenza. In mid-November, the firm posted earnings for the third quarter of 2024. The revenue over the period was €493.9 million, while pre-tax profit was €370.6 million.

Page 2 of 12